Fresenius SE & Co. KGaA

“sold 7.8 million shares of its listed subsidiary Fresenius Medical Care AG (FMC) to institutional investors for an estimated €300 million.”

“reduces Fresenius’ direct ownership from 27.8 % to roughly 25 % of FMC’s share capital.”